Why St. Jude for Recurrent Pediatric Cancers?
St. Jude is the only pediatric specialty cancer center funded by the National Cancer Institute and the only private cancer center in the United States committed to caring for and supporting children with cancer regardless of the family’s financial or healthcare resources. St. Jude’s research and patient care are housed on the same campus, allowing scientists and clinicians interested in Phase I and Phase II studies to work together as a team called the Developmental Therapeutics Team. This interdisciplinary team includes physicians specializing in the development of Phase I and Phase II trials, research nurses, clinical research coordinators, biostatisticians, pharmacists, and basic scientists who rely on shared resources to support the design, implementation, analysis, interpretation and reporting of research. Your child will be accepted for treatment at St. Jude if he/she is eligible for a clinical study.
